WEKO3
アイテム
{"_buckets": {"deposit": "97beb16b-48fa-426d-aabd-d81b8e0869ff"}, "_deposit": {"created_by": 2, "id": "21912", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "21912"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00021912", "sets": ["1561"]}, "author_link": ["93468", "93466", "93467", "93469", "93465"], "item_3_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1990-12-14", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "1-4", "bibliographicPageEnd": "80", "bibliographicPageStart": "77", "bibliographicVolumeNumber": "35", "bibliographic_titles": [{"bibliographic_title": "Acta medica Nagasakiensia"}]}]}, "item_3_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "To assess the efficacy and possible potential side effects of alternate routes of treatment, 2.5mg bromocriptine was administered vaginally or rectally to five normoprolactinemic and four idiopathic hyperprolactinemic women. Serum bromocriptine and prolactin (PRL) levels were measured hourly for the first 12 hours, then every 2 hours for the following 12 hours. The mean peak bromocriptine levels were 641.0 ± 200.1 pg/ml and 386.5 ± 134.8 pg/ml in the normoprolactinemic and hyperprolactinemic groups, respectively. Maximum PRL reduction rate was 67.7 ± 3.4% at 11.3 ± 1.1 hours and 44.8 ± 0.7% at 21.5 ± 1.5 hours after vaginal administration in the normoprolactinemic and hyperprolactinemic groups, respectively. In contrast, in the rectal treatment group the mean peak values of serum bromocriptine were 364 pg/ml and 314.5 ± 3.9 pg/ml in the normoprolactinemic and hyperprolactinemic groups, respectively. Maximum PRL reduction rate was 38.1% at 8 hours and 21.0 ± 10.4% at 17.0 ± 3.5 hours in the normoprolactinemic and hyperprolactinemic gryoups, respectively. In conclusion, we suggest that the vaginal route of administration is as effective and has fewer side effects than by the oral route. Furthermore, the rectal route is an alternate method of treatment for patients who cannot be administered bromocriptine by vaginal route.", "subitem_description_type": "Abstract"}]}, "item_3_description_64": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Acta medica Nagasakiensia. 1990, 35(1-4), p.77-80", "subitem_description_type": "Other"}]}, "item_3_source_id_10": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AA00508430", "subitem_source_identifier_type": "NCID"}]}, "item_3_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00016055", "subitem_source_identifier_type": "ISSN"}]}, "item_3_text_62": {"attribute_name": "sortkey", "attribute_value_mlt": [{"subitem_text_value": "P00077-P00080"}]}, "item_3_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Ishimaru, Tadayuki"}], "nameIdentifiers": [{"nameIdentifier": "93465", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Huang, Hung"}], "nameIdentifiers": [{"nameIdentifier": "93466", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ikuji, nfan"}], "nameIdentifiers": [{"nameIdentifier": "93467", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kajimura, Hideo"}], "nameIdentifiers": [{"nameIdentifier": "93468", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamabe, Tooru"}], "nameIdentifiers": [{"nameIdentifier": "93469", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-23"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "acta35_01_17_t.pdf", "filesize": [{"value": "351.3 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 351300.0, "url": {"label": "acta35_01_17_t.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/21912/files/acta35_01_17_t.pdf"}, "version_id": "52dba25d-b8cb-4be3-8d0a-6f471e663a0c"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "A Comparative Study between Vaginal and Rectal Routs of Bromocriptine Administration", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "A Comparative Study between Vaginal and Rectal Routs of Bromocriptine Administration"}]}, "item_type_id": "3", "owner": "2", "path": ["1561"], "permalink_uri": "http://hdl.handle.net/10069/15817", "pubdate": {"attribute_name": "公開日", "attribute_value": "2008-03-13"}, "publish_date": "2008-03-13", "publish_status": "0", "recid": "21912", "relation": {}, "relation_version_is_last": true, "title": ["A Comparative Study between Vaginal and Rectal Routs of Bromocriptine Administration"], "weko_shared_id": -1}
A Comparative Study between Vaginal and Rectal Routs of Bromocriptine Administration
http://hdl.handle.net/10069/15817
http://hdl.handle.net/10069/15817f0f894f8-634d-47aa-8e12-97a9bfe0d4ee
名前 / ファイル | ライセンス | アクション |
---|---|---|
acta35_01_17_t.pdf (351.3 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2008-03-13 | |||||
タイトル | ||||||
タイトル | A Comparative Study between Vaginal and Rectal Routs of Bromocriptine Administration | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | departmental bulletin paper | |||||
著者 |
Ishimaru, Tadayuki
× Ishimaru, Tadayuki× Huang, Hung× Ikuji, nfan× Kajimura, Hideo× Yamabe, Tooru |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | To assess the efficacy and possible potential side effects of alternate routes of treatment, 2.5mg bromocriptine was administered vaginally or rectally to five normoprolactinemic and four idiopathic hyperprolactinemic women. Serum bromocriptine and prolactin (PRL) levels were measured hourly for the first 12 hours, then every 2 hours for the following 12 hours. The mean peak bromocriptine levels were 641.0 ± 200.1 pg/ml and 386.5 ± 134.8 pg/ml in the normoprolactinemic and hyperprolactinemic groups, respectively. Maximum PRL reduction rate was 67.7 ± 3.4% at 11.3 ± 1.1 hours and 44.8 ± 0.7% at 21.5 ± 1.5 hours after vaginal administration in the normoprolactinemic and hyperprolactinemic groups, respectively. In contrast, in the rectal treatment group the mean peak values of serum bromocriptine were 364 pg/ml and 314.5 ± 3.9 pg/ml in the normoprolactinemic and hyperprolactinemic groups, respectively. Maximum PRL reduction rate was 38.1% at 8 hours and 21.0 ± 10.4% at 17.0 ± 3.5 hours in the normoprolactinemic and hyperprolactinemic gryoups, respectively. In conclusion, we suggest that the vaginal route of administration is as effective and has fewer side effects than by the oral route. Furthermore, the rectal route is an alternate method of treatment for patients who cannot be administered bromocriptine by vaginal route. | |||||
書誌情報 |
Acta medica Nagasakiensia 巻 35, 号 1-4, p. 77-80, 発行日 1990-12-14 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00016055 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AA00508430 | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
sortkey | ||||||
P00077-P00080 | ||||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Acta medica Nagasakiensia. 1990, 35(1-4), p.77-80 |